125 related articles for article (PubMed ID: 36967102)
1. Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.
Haan D; Bergamaschi A; Friedl V; Guler GD; Ning Y; Reggiardo R; Kesling M; Collins M; Gibb B; Hazen K; Bates S; Antoine M; Fraire C; Lopez V; Malta R; Nabiyouni M; Nguyen A; Phillips T; Riviere M; Leighton A; Ellison C; McCarthy E; Scott A; Gigliotti L; Nilson E; Sheard J; Peters M; Bethel K; Chowdhury S; Volkmuth W; Levy S
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1802-1809.e6. PubMed ID: 36967102
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.
Mizuno S; Nakai Y; Isayama H; Yanai A; Takahara N; Miyabayashi K; Yamamoto K; Kawakubo K; Mohri D; Kogure H; Sasaki T; Yamamoto N; Sasahira N; Hirano K; Tsujino T; Ijichi H; Tateishi K; Akanuma M; Tada M; Koike K
J Gastroenterol; 2013 Feb; 48(2):238-46. PubMed ID: 22735942
[TBL] [Abstract][Full Text] [Related]
3. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
4. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
[TBL] [Abstract][Full Text] [Related]
5. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening.
Zhang Z; Qin W; Sun Y
Pathol Res Pract; 2018 Dec; 214(12):1923-1928. PubMed ID: 30477640
[TBL] [Abstract][Full Text] [Related]
6. Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes.
Schwartz NRM; Matrisian LM; Shrader EE; Feng Z; Chari S; Roth JA
J Natl Compr Canc Netw; 2021 Jun; 20(5):451-459. PubMed ID: 34153945
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
9. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
[TBL] [Abstract][Full Text] [Related]
10. Early Diagnosis of Pancreatic Cancer via Machine Learning Analysis of a National Electronic Medical Record Database.
Matchaba S; Fellague-Chebra R; Purushottam P; Johns A
JCO Clin Cancer Inform; 2023 Sep; 7():e2300076. PubMed ID: 37816199
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers.
Aggarwal G; Kamada P; Chari ST
Pancreas; 2013 Mar; 42(2):198-201. PubMed ID: 23000893
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.
Eissa MAL; Lerner L; Abdelfatah E; Shankar N; Canner JK; Hasan NM; Yaghoobi V; Huang B; Kerner Z; Takaesu F; Wolfgang C; Kwak R; Ruiz M; Tam M; Pisanic TR; Iacobuzio-Donahue CA; Hruban RH; He J; Wang TH; Wood LD; Sharma A; Ahuja N
Clin Epigenetics; 2019 Apr; 11(1):59. PubMed ID: 30953539
[TBL] [Abstract][Full Text] [Related]
13. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
Balasenthil S; Huang Y; Liu S; Marsh T; Chen J; Stass SA; KuKuruga D; Brand R; Chen N; Frazier ML; Jack Lee J; Srivastava S; Sen S; McNeill Killary A
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376184
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles.
Ding Z; Wu H; Zhang J; Huang G; Ji D
Tumour Biol; 2014 Sep; 35(9):8837-48. PubMed ID: 24880590
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
[TBL] [Abstract][Full Text] [Related]
16. Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes.
Sharaf RN; Butte AJ; Montgomery KD; Pai R; Dudley JT; Pasricha PJ
BMC Gastroenterol; 2011 Jan; 11():5. PubMed ID: 21251264
[TBL] [Abstract][Full Text] [Related]
17. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.
Zhang L; Farrell JJ; Zhou H; Elashoff D; Akin D; Park NH; Chia D; Wong DT
Gastroenterology; 2010 Mar; 138(3):949-57.e1-7. PubMed ID: 19931263
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes.
Shi W; Qiu W; Wang W; Zhou X; Zhong X; Tian G; Deng A
Biosci Trends; 2014 Dec; 8(6):322-6. PubMed ID: 25641178
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
20. The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study.
Mueller AM; Meier CR; Jick SS; Schneider C
Pancreas; 2018 Aug; 47(7):807-815. PubMed ID: 29975346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
